2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
Primary completion pushed from Dec 2025 to Jan 2027
Also in this update: Enrollment reduced: 330 → 258 participants; Study completion pushed from Dec 2025 to Jun 2027
Amsterdam UMC, location VUmcPhase 4 NCT05216328 Registry history of NCT05216328 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 94 participants (planned 140)
Amsterdam UMC, location VUmcPhase 3 NCT05415397 Registry history of NCT05415397 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-07 | NCT07863336 ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic… | Not Yet Recruiting | |
| 2026-09-29 | NCT07846046 Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer | Not Yet Recruiting |
| Phase 1/2 | 2 | |
| Phase 2 | 4 | |
| Phase 2/3 | 2 | |
| Phase 3 | 3 | |
| Phase 4 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05216328 | Prevention of Opioid-induced Constipation in Patients With Advanced Cancer | Constipation, Opioid-Induced | Recruiting | 2026-10-05 |
| NCT06658522 | Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label… | Pulmonary Arterial Hypertension PAH | Recruiting | 2025-09-22 |
| NCT06983054 | DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation… | Type 2 Diabetes | Recruiting | 2025-05-21 |
| NCT07781722 | Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis | Post-ERCP Pancreatitis | Not Yet Recruiting | 2026-08-24 |
| NCT05296161 | B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple… | Multiple Sclerosis, Relapsing-Remitting | Active, Not Recruiting | 2026-06-10 |
| Phase 3 | ||||
| NCT05331937 | TMS for Exposure Therapy Resistant OCD | 1 Hz Real rTMS to the Pre-SMA | Recruiting | 2026-03-04 |
| NCT05861505 | COLLISION RELAPSE Trial | Colorectal Cancer | Recruiting | 2023-05-17 |
| NCT05834855 | Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS | Multiple Sclerosis | Recruiting | 2023-04-28 |
| Phase 2/3 | ||||
| NCT06923475 | Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab… | Extrahepatic Cholangiocarcinoma | Recruiting | 2026-08-25 |
| NCT06185556 | COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body… | Colorectal Cancer | Recruiting | 2024-08-23 |
| Phase 2 | ||||
| NCT06640881 | Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in… | Recurrent Breast Carcinoma | Recruiting | 2026-07-16 |
| NCT06687876 | Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response… | Oesophageal Adenocarcinoma | Recruiting | 2025-07-10 |
| NCT04307953 | Saracatinib Trial TO Prevent FOP | Fibrodysplasia Ossificans Progressiva | Active, Not Recruiting | 2026-09-02 |
| NCT04392037 | Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone | Multiple Myeloma | Active, Not Recruiting | 2025-03-28 |
| Phase 1/2 | ||||
| NCT06384560 | Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) | Localized Pancreatic Adenocarcinoma | Recruiting | 2026-02-13 |
| NCT07615881 | Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With… | Melanoma (Skin Cancer) | Not Yet Recruiting | 2026-05-29 |
| Not applicable | ||||
| NCT06327750 | The Microcirculation, Dialysis Modality and Sequestered Salt | End-stage Renal Disease | Recruiting | 2026-09-11 |
| NCT06824961 | Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression… | Cardiac Arrest (CA) | Recruiting | 2026-08-21 |
| NCT05900271 | Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst… | Treatment Resistant Depression | Recruiting | 2026-08-20 |
| NCT05701176 | A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy… | Advanced Stage Non-small Cell Lung Cancer | Recruiting | 2026-08-18 |
| NCT06457789 | Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to… | NSCLC | Recruiting | 2026-08-18 |
| NCT05350722 | Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients | Breast Cancer | Recruiting | 2026-07-16 |
| NCT06416345 | Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External… | Parkinson Disease | Recruiting | 2026-03-16 |
| NCT07380217 | Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures | High-risk PCI | Recruiting | 2026-02-02 |
| NCT06640894 | Power2Walk: The Impact of Functional Power Training on Participation and Activity in… | Cerebral Palsy, Spastic | Recruiting | 2025-12-29 |
Heart Disease (9) · Colorectal Cancer (8) · Coronary Artery Disease (5) · Multiple Sclerosis (5) · Breast Cancer (4) · Lung Cancer (4) · Non-Small Cell Lung Cancer (NSCLC) (3) · Anxiety (2) · Melanoma (2) · Pancreatic Cancer (2)